Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × Vigabatrin × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Seizures 1

Interventions

Cyclophosphamide 238 Radiotherapy 215 Gemcitabine 186 Cisplatin 185 Carboplatin 181 Docetaxel 165 Bevacizumab 165 Paclitaxel 144 Capecitabine 141 Rituximab 140 pembrolizumab 137 Oxaliplatin 124 Dexamethasone 121 Nivolumab 120 Fluorouracil 113 fludarabine 102 Radiosurgery 99 Doxorubicin 99 Irinotecan 96 fludarabine phosphate 95 Etoposide 95 Lenalidomide 92 Radiation 89 Cytarabine 89 Leucovorin 88 Filgrastim 88 Magnetic Resonance Spectroscopy 87 Bortezomib 85 Temozolomide 78 Pemetrexed 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01266291 2017-07-12

STARS

University of Pennsylvania

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡